Official opening of the new tablet production facility in Cork (Ireland) in the presence of the Irish Prime Minister Bertie Ahern; Serving growing markets with ALTANA’s strategically important products
July 7, 2006 — /BUSINESS WIRE/ — BAD HOMBURG, Germany & CORK, Ireland — ALTANA Pharma, the pharmaceutical division of ALTANA AG today performed the official opening of a new tablet production facility in Cork (Ireland) in the presence of the Irish Prime Minister, Mr. Bertie Ahern. The new plant will play an important role in ALTANA Pharma’s global production network and provide extended capacity for the manufacturing of existing and future products.
“The facility in Cork means that in addition to Oranienburg (Germany) ALTANA Pharma will have a second state-of-the-art, high-quality manufacturing site for solid formulations meeting the strictest international standards. This will provide greater flexibility and security in terms of supplying the market with our strategically important products,” commented Dr. Hans-Joachim Lohrisch, CEO of ALTANA Pharma AG, at the official opening ceremony.
The Irish Prime Minister Bertie Ahern paid tribute to ALTANA’s commitment in Cork. “We are delighted that ALTANA Pharma chose Cork as the second hub in its global manufacturing strategy. ALTANA Pharma is one of the fastest growing, most profitable pharmaceutical companies in Europe. I am very pleased that the company has a particularly strong emphasis on research and development. This is a great day for Carrigtohill, for the pharmaceutical industry and for Cork.”
“The technology applied reflects ALTANA’s commitment to innovation,” said Dr. Declan Farrell, Managing Director of ALTANA Pharma’s facility in Cork. “This means highly automated production equipment, producing products in a clean and environmentally sound manner, sophisticated IT systems as well as a modular design concept and an excellent work environment for the employees.”
The tablet manufacturing facility on the eleven hectare plot in the Carrigtohill Industrial Park in Cork required an investment of EUR 67 million. As of today the company employs 56 people. At full operational level some 150 employees will be able to produce three billion tablets a year.
With demand for ALTANA’s Pantoprazole, currently the most successful medicine from a German research laboratory and used in the treatment of acid-related gastrointestinal disorders, still rising, Cork will complement the production site in Oranienburg as a second tabletting site within the Pantoprazole supply chain.
Dr. Thomas Gauly
P + 49 (0) 6172 1712-160
P + 49 (0) 6172 1712-150
F + 49 (0) 6172 1712-158
P + 49 (0) 6172 1712-163
P + 49 (0) 6172 1712-165
F + 49 (0) 6172 1712-158
Investor Relations USA:
P +1 212 974 98 00
F +1 212 974 61 90